COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges-Reference-Cited by-同舟云学术

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Published:2021-09-01 Issue:11 Volume:47 Page:1339-1340
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Prattes Juergen^ORCID,Koehler Philipp^ORCID,Hoenigl Martin^ORCID,Wauters Joost,Giacobbe Daniele Roberto,Lagrou Katrien,Salmanton-García Jon,Rautemaa-Richardson Riina,Hatzl Stefan,Maertens Johan,Debaveye Yves,Bourgeois Marc,Reynders Marijke,Rutsaert Lynn,Van Regenmortel Niels,Lormans Piet,Feys Simon,Reisinger Alexander Christian,Cornely Oliver A.,Lahmer Tobias,Valerio Maricela,Delhaes Laurence,Jabeen Kauser,Steinmann Joerg,Chamula Mathilde,Bassetti Matteo,

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00134-021-06510-2.pdf

Reference5 articles.

1. Rouze A, Lemaitre E, Nseir S (2021) COVID-19-associated pulmonary invasive aspergillosis: high incidence or difficult diagnosis? Intensive Care Med. https://doi.org/10.1007/s00134-021-06499-8

2. Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M, Group E-CS (2021) Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med

3. Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomeli P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF (2021) Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses 64:364–371

4. Fekkar A, Neofytos D, Nguyen MH, Clancy CJ, Kontoyiannis DP, Lamoth F (2021) COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases

5. Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Richardson R, Lagrou K, Hoenigl M (2021) Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients– a multinational observational study by the European Confederation of Medical Mycology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2021.08.014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of severe COVID-19 in the ICU;COVID-19: An Update;2024-09-01

2. Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associated pulmonary aspergillosis: Cross‐sectional and systematic review of literature;Mycoses;2024-08

3. Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid;Mycopathologia;2024-07-18

4. A prediction model for secondary invasive fungal infection among severe SARS-CoV-2 positive patients in ICU;Frontiers in Cellular and Infection Microbiology;2024-07-08

5. Predicting COVID 19–Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study;Open Forum Infectious Diseases;2024-06-28